These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Contraception and pelvic infection in women]. Keith L, Berger GS, Brown ER. Contracept Fertil Sex (Paris); 1986 Jan 28; 14(1):49-58. PubMed ID: 12341241 [Abstract] [Full Text] [Related]
31. Pelvic actinomycosis associated with use of intrauterine device: a new challenge for the surgeon. Doberneck RC. Am Surg; 1982 Jan 28; 48(1):25-7. PubMed ID: 7065552 [Abstract] [Full Text] [Related]
33. Role of sexual behavior in the development of pelvic inflammatory disease. Newton W, Keith LG. J Reprod Med; 1985 Feb 28; 30(2):82-8. PubMed ID: 3884805 [Abstract] [Full Text] [Related]
35. Risk of PID 5x greater from Dalkon Shield than from other IUDs. Fam Plann Perspect; 1983 Feb 28; 15(5):225-6. PubMed ID: 6653739 [Abstract] [Full Text] [Related]
36. A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: a paradigm for assessing intrauterine contraceptive device safety. Roy S, Azen C. Am J Obstet Gynecol; 1994 Jun 28; 170(6):1606-13; discussion 1613-6. PubMed ID: 8203417 [Abstract] [Full Text] [Related]
37. Long-term study of the safety of the Dalkon Shield and Gyne-T 200 intrauterine devices. Rioux JE, Cloutier D, Dupont P, Lamonde D. CMAJ; 1986 Apr 01; 134(7):747-51. PubMed ID: 3948091 [Abstract] [Full Text] [Related]
38. [The use of IUD as an etiological factor of acute pelvic inflammatory disease]. Evron S, Schenker JG. Harefuah; 1979 Apr 01; 96(7):344-6. PubMed ID: 385465 [Abstract] [Full Text] [Related]